| Title |
A first-in-human study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of KM-819 (FAS-associated factor 1 inhibitor), a drug for Parkinson’s disease, in healthy volunteers
|
|---|---|
| Published in |
Drug Design, Development and Therapy, March 2019
|
| DOI | 10.2147/dddt.s198753 |
| Pubmed ID | |
| Authors |
Wonsuk Shin, Kyoung Soo Lim, Min-Kyoung Kim, Hyun Sook Kim, Jihwa Hong, Stanford Jhee, Joseph Kim, Sungeun Yoo, Yeon-Tae Chung, Jae Moon Lee, Doo-Yeoun Cho |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 57 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 9 | 16% |
| Student > Bachelor | 8 | 14% |
| Student > Ph. D. Student | 6 | 11% |
| Librarian | 2 | 4% |
| Student > Doctoral Student | 1 | 2% |
| Other | 2 | 4% |
| Unknown | 29 | 51% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 16% |
| Nursing and Health Professions | 4 | 7% |
| Biochemistry, Genetics and Molecular Biology | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 5% |
| Neuroscience | 3 | 5% |
| Other | 4 | 7% |
| Unknown | 31 | 54% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 January 2023.
All research outputs
#3,711,927
of 25,385,509 outputs
Outputs from Drug Design, Development and Therapy
#231
of 2,268 outputs
Outputs of similar age
#79,930
of 367,999 outputs
Outputs of similar age from Drug Design, Development and Therapy
#4
of 39 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,999 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.